Barclays’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $912K | Sell |
244,637
-408,400
| -63% | -$1.52M | ﹤0.01% | 2716 |
|
|
2025
Q1 | $1.8M | Sell |
653,037
-51,334
| -7% | -$142K | ﹤0.01% | 2097 |
|
|
2024
Q4 | $3.9M | Buy |
704,371
+609,469
| +642% | +$3.38M | ﹤0.01% | 1777 |
|
|
2024
Q3 | $792K | Sell |
94,902
-100,540
| -51% | -$839K | ﹤0.01% | 2755 |
|
|
2024
Q2 | $1.33M | Sell |
195,442
-52,862
| -21% | -$360K | ﹤0.01% | 1950 |
|
|
2024
Q1 | $1.63M | Buy |
248,304
+163,722
| +194% | +$1.07M | ﹤0.01% | 2082 |
|
|
2023
Q4 | $548K | Buy |
84,582
+30,255
| +56% | +$196K | ﹤0.01% | 2946 |
|
|
2023
Q3 | $274K | Sell |
54,327
-208,591
| -79% | -$1.05M | ﹤0.01% | 2871 |
|
|
2023
Q2 | $2.3M | Sell |
262,918
-271,842
| -51% | -$2.38M | ﹤0.01% | 1658 |
|
|
2023
Q1 | $6.33M | Buy |
534,760
+18,021
| +3% | +$213K | ﹤0.01% | 977 |
|
|
2022
Q4 | $5.26M | Sell |
516,739
-142,359
| -22% | -$1.45M | ﹤0.01% | 1080 |
|
|
2022
Q3 | $3.88M | Buy |
659,098
+645,973
| +4,922% | +$3.8M | ﹤0.01% | 1243 |
|
|
2022
Q2 | $33K | Sell |
13,125
-2,227
| -15% | -$5.6K | ﹤0.01% | 3900 |
|
|
2022
Q1 | $46K | Buy |
+15,352
| New | +$46K | ﹤0.01% | 4037 |
|